22nd Century Group Inc (XXII)

[brooklyn13]

I'm not sure I remember correctly, but isn't K2 a synthetic marijuana and wasn't it killing a bunch of people? If so, that's a good reason it never caught on.

But something I do know a little about is biotech, especially small caps. I think you'd find that about 90%, maybe less, run up into the P2 and P3 result announcements then sell off immediately afterwards. Sure, there are exceptions, I had A--P, which went from .80 to $40 in 2 days, but it was a singular experience and people win the lottery, too.

I think it's great that you're so optimistic about XXII, I hope you're right. But, you sort of dodge the question I asked, when you write:

"They will finally start generating revenue and become a growth company."

The key word, to me, is "finally". My question was, how long will it take to start generating substantial revenue in a retail space where there's strong loyalty to existing brands, shelf space has to be appropriated, and advertising is forbidden? No tobacconist is going to give prominent placement to a new brand that's hardly selling.

I'm guessing maybe a year or two and that will include continuing negative revenue reports while production and sales ramp up. And that's one of the reasons why BT is in no rush to buy us. I don't think there will be a mandate and I don't think the FDA will allow VLN to be prescribed as a smoking cessation drug, because then they will be the only ciggies in the world that can be advertised on tv.